Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
9
11
2023
pubmed:
9
11
2023
entrez:
9
11
2023
Statut:
epublish
Résumé
[This corrects the article DOI: 10.1371/journal.pone.0233499.].
Identifiants
pubmed: 37943757
doi: 10.1371/journal.pone.0294379
pii: PONE-D-23-36084
pmc: PMC10635459
doi:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0294379Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright: © 2023 Mahumud et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Références
PLoS One. 2020 Jun 2;15(6):e0233499
pubmed: 32484811